197 related articles for article (PubMed ID: 30409302)
1. From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.
Spector ME; Rosko AJ; Swiecicki PL; Chad Brenner J; Birkeland AC
Oral Oncol; 2018 Nov; 86():200-205. PubMed ID: 30409302
[TBL] [Abstract][Full Text] [Related]
2. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
3. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy in head and neck cancers: Results and controversies.
Gau M; Karabajakian A; Reverdy T; Neidhardt EM; Fayette J
Oral Oncol; 2019 Aug; 95():164-169. PubMed ID: 31345386
[TBL] [Abstract][Full Text] [Related]
5. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
6. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
8. Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial.
Ou X; Zhai R; Wei W; Chen J; Ou D; Liao T; Xu T; Zhu Y; Wang Y; Huang S; Shi R; Wu B; Chen T; Li Y; Yang Z; Zhou C; Liu Y; Jiang Z; Zeng M; Liu X; Ji D; Ying H; Zhang Z; Hu C; Lu X; Ji Q; He X; Wang Y
Clin Cancer Res; 2024 Jan; 30(2):344-355. PubMed ID: 37955629
[TBL] [Abstract][Full Text] [Related]
9. Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies.
Bonomi MR; Blakaj A; Blakaj D
Oral Oncol; 2018 Nov; 86():301-306. PubMed ID: 30409316
[TBL] [Abstract][Full Text] [Related]
10. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Guadagnolo BA; Haddad RI; Posner MR; Weeks L; Wirth LJ; Norris CM; Sullivan CA; Goguen L; Busse PM; Tishler R
Am J Clin Oncol; 2005 Aug; 28(4):371-8. PubMed ID: 16062079
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.
Forastiere AA; Zhang Q; Weber RS; Maor MH; Goepfert H; Pajak TF; Morrison W; Glisson B; Trotti A; Ridge JA; Thorstad W; Wagner H; Ensley JF; Cooper JS
J Clin Oncol; 2013 Mar; 31(7):845-52. PubMed ID: 23182993
[TBL] [Abstract][Full Text] [Related]
12. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
[TBL] [Abstract][Full Text] [Related]
13. Decision making in advanced larynx cancer: An evidenced based review.
Eskander A; Blakaj DM; Dziegielewski PT
Oral Oncol; 2018 Nov; 86():195-199. PubMed ID: 30409301
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions.
Haddad RI; Posner M; Hitt R; Cohen EEW; Schulten J; Lefebvre JL; Vermorken JB
Ann Oncol; 2018 May; 29(5):1130-1140. PubMed ID: 29635316
[TBL] [Abstract][Full Text] [Related]
15. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
[TBL] [Abstract][Full Text] [Related]
16. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Forastiere AA; Ismaila N; Lewin JS; Nathan CA; Adelstein DJ; Eisbruch A; Fass G; Fisher SG; Laurie SA; Le QT; O'Malley B; Mendenhall WM; Patel S; Pfister DG; Provenzano AF; Weber R; Weinstein GS; Wolf GT
J Clin Oncol; 2018 Apr; 36(11):1143-1169. PubMed ID: 29172863
[TBL] [Abstract][Full Text] [Related]
17. Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma.
Nakata Y; Hanai N; Nishikawa D; Suzuki H; Koide Y; Fukuda Y; Nomura M; Kodaira T; Shimizu T; Hasegawa Y
Int J Clin Oncol; 2017 Dec; 22(6):1034-1041. PubMed ID: 28623448
[TBL] [Abstract][Full Text] [Related]
18. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
Fong PY; Tan SH; Lim DWT; Tan EH; Ng QS; Sommat K; Tan DSW; Ang MK
PLoS One; 2019; 14(11):e0224665. PubMed ID: 31747406
[TBL] [Abstract][Full Text] [Related]
19. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
Cmelak AJ; Li S; Goldwasser MA; Murphy B; Cannon M; Pinto H; Rosenthal DI; Gillison M; Forastiere AA
J Clin Oncol; 2007 Sep; 25(25):3971-7. PubMed ID: 17761982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
